Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Genetic Virus Vector Market Growth (Status and Outlook) 2022-2028

  • LP 4884858
  • 104 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Genetic Virus Vector will have significant change from previous year. According to our (LP Information) latest study, the global Genetic Virus Vector market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Genetic Virus Vector market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Genetic Virus Vector market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Genetic Virus Vector market, reaching US$ million by the year 2028. As for the Europe Genetic Virus Vector landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Genetic Virus Vector players cover FUJIFILM Diosynth Biotechnologies U.S.A., Sanofi, Lonza, and Merck KGaA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Virus Vector market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Retroviral Vectors

Adenoviral Vectors

Adeno-Associated Viral Vectors

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Gene Therapy

Vaccinology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

FUJIFILM Diosynth Biotechnologies U.S.A.

Sanofi

Lonza

Merck KGaA

GENERAL ELECTRIC COMPANY

Oxford BioMedica

Spark Therapeutics, Inc.

uniQure N.V.

FinVector Vision Therapies

Brammer Bio

Cell and Gene Therapy Catapult

Cobra Biologics

REGENXBIO Inc.

Kaneka Eurogentec S.A.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Genetic Virus Vector Market Size 2017-2028

2.1.2 Genetic Virus Vector Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Genetic Virus Vector Segment by Type

2.2.1 Retroviral Vectors

2.2.2 Adenoviral Vectors

2.2.3 Adeno-Associated Viral Vectors

2.2.4 Other

2.3 Genetic Virus Vector Market Size by Type

2.3.1 Genetic Virus Vector Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Genetic Virus Vector Market Size Market Share by Type (2017-2022)

2.4 Genetic Virus Vector Segment by Application

2.4.1 Gene Therapy

2.4.2 Vaccinology

2.5 Genetic Virus Vector Market Size by Application

2.5.1 Genetic Virus Vector Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Genetic Virus Vector Market Size Market Share by Application (2017-2022)

3 Genetic Virus Vector Market Size by Player

3.1 Genetic Virus Vector Market Size Market Share by Players

3.1.1 Global Genetic Virus Vector Revenue by Players (2020-2022)

3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2020-2022)

3.2 Global Genetic Virus Vector Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Genetic Virus Vector by Regions

4.1 Genetic Virus Vector Market Size by Regions (2017-2022)

4.2 Americas Genetic Virus Vector Market Size Growth (2017-2022)

4.3 APAC Genetic Virus Vector Market Size Growth (2017-2022)

4.4 Europe Genetic Virus Vector Market Size Growth (2017-2022)

4.5 Middle East & Africa Genetic Virus Vector Market Size Growth (2017-2022)

5 Americas

5.1 Americas Genetic Virus Vector Market Size by Country (2017-2022)

5.2 Americas Genetic Virus Vector Market Size by Type (2017-2022)

5.3 Americas Genetic Virus Vector Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Genetic Virus Vector Market Size by Region (2017-2022)

6.2 APAC Genetic Virus Vector Market Size by Type (2017-2022)

6.3 APAC Genetic Virus Vector Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Genetic Virus Vector by Country (2017-2022)

7.2 Europe Genetic Virus Vector Market Size by Type (2017-2022)

7.3 Europe Genetic Virus Vector Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Genetic Virus Vector by Region (2017-2022)

8.2 Middle East & Africa Genetic Virus Vector Market Size by Type (2017-2022)

8.3 Middle East & Africa Genetic Virus Vector Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Genetic Virus Vector Market Forecast

10.1 Global Genetic Virus Vector Forecast by Regions (2023-2028)

10.1.1 Global Genetic Virus Vector Forecast by Regions (2023-2028)

10.1.2 Americas Genetic Virus Vector Forecast

10.1.3 APAC Genetic Virus Vector Forecast

10.1.4 Europe Genetic Virus Vector Forecast

10.1.5 Middle East & Africa Genetic Virus Vector Forecast

10.2 Americas Genetic Virus Vector Forecast by Country (2023-2028)

10.2.1 United States Genetic Virus Vector Market Forecast

10.2.2 Canada Genetic Virus Vector Market Forecast

10.2.3 Mexico Genetic Virus Vector Market Forecast

10.2.4 Brazil Genetic Virus Vector Market Forecast

10.3 APAC Genetic Virus Vector Forecast by Region (2023-2028)

10.3.1 China Genetic Virus Vector Market Forecast

10.3.2 Japan Genetic Virus Vector Market Forecast

10.3.3 Korea Genetic Virus Vector Market Forecast

10.3.4 Southeast Asia Genetic Virus Vector Market Forecast

10.3.5 India Genetic Virus Vector Market Forecast

10.3.6 Australia Genetic Virus Vector Market Forecast

10.4 Europe Genetic Virus Vector Forecast by Country (2023-2028)

10.4.1 Germany Genetic Virus Vector Market Forecast

10.4.2 France Genetic Virus Vector Market Forecast

10.4.3 UK Genetic Virus Vector Market Forecast

10.4.4 Italy Genetic Virus Vector Market Forecast

10.4.5 Russia Genetic Virus Vector Market Forecast

10.5 Middle East & Africa Genetic Virus Vector Forecast by Region (2023-2028)

10.5.1 Egypt Genetic Virus Vector Market Forecast

10.5.2 South Africa Genetic Virus Vector Market Forecast

10.5.3 Israel Genetic Virus Vector Market Forecast

10.5.4 Turkey Genetic Virus Vector Market Forecast

10.5.5 GCC Countries Genetic Virus Vector Market Forecast

10.6 Global Genetic Virus Vector Forecast by Type (2023-2028)

10.7 Global Genetic Virus Vector Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 FUJIFILM Diosynth Biotechnologies U.S.A.

11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Information

11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product Offered

11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Main Business Overview

11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Genetic Virus Vector Product Offered

11.2.3 Sanofi Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Lonza

11.3.1 Lonza Company Information

11.3.2 Lonza Genetic Virus Vector Product Offered

11.3.3 Lonza Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Lonza Main Business Overview

11.3.5 Lonza Latest Developments

11.4 Merck KGaA

11.4.1 Merck KGaA Company Information

11.4.2 Merck KGaA Genetic Virus Vector Product Offered

11.4.3 Merck KGaA Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck KGaA Main Business Overview

11.4.5 Merck KGaA Latest Developments

11.5 GENERAL ELECTRIC COMPANY

11.5.1 GENERAL ELECTRIC COMPANY Company Information

11.5.2 GENERAL ELECTRIC COMPANY Genetic Virus Vector Product Offered

11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GENERAL ELECTRIC COMPANY Main Business Overview

11.5.5 GENERAL ELECTRIC COMPANY Latest Developments

11.6 Oxford BioMedica

11.6.1 Oxford BioMedica Company Information

11.6.2 Oxford BioMedica Genetic Virus Vector Product Offered

11.6.3 Oxford BioMedica Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Oxford BioMedica Main Business Overview

11.6.5 Oxford BioMedica Latest Developments

11.7 Spark Therapeutics, Inc.

11.7.1 Spark Therapeutics, Inc. Company Information

11.7.2 Spark Therapeutics, Inc. Genetic Virus Vector Product Offered

11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Spark Therapeutics, Inc. Main Business Overview

11.7.5 Spark Therapeutics, Inc. Latest Developments

11.8 uniQure N.V.

11.8.1 uniQure N.V. Company Information

11.8.2 uniQure N.V. Genetic Virus Vector Product Offered

11.8.3 uniQure N.V. Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 uniQure N.V. Main Business Overview

11.8.5 uniQure N.V. Latest Developments

11.9 FinVector Vision Therapies

11.9.1 FinVector Vision Therapies Company Information

11.9.2 FinVector Vision Therapies Genetic Virus Vector Product Offered

11.9.3 FinVector Vision Therapies Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 FinVector Vision Therapies Main Business Overview

11.9.5 FinVector Vision Therapies Latest Developments

11.10 Brammer Bio

11.10.1 Brammer Bio Company Information

11.10.2 Brammer Bio Genetic Virus Vector Product Offered

11.10.3 Brammer Bio Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Brammer Bio Main Business Overview

11.10.5 Brammer Bio Latest Developments

11.11 Cell and Gene Therapy Catapult

11.11.1 Cell and Gene Therapy Catapult Company Information

11.11.2 Cell and Gene Therapy Catapult Genetic Virus Vector Product Offered

11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Cell and Gene Therapy Catapult Main Business Overview

11.11.5 Cell and Gene Therapy Catapult Latest Developments

11.12 Cobra Biologics

11.12.1 Cobra Biologics Company Information

11.12.2 Cobra Biologics Genetic Virus Vector Product Offered

11.12.3 Cobra Biologics Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Cobra Biologics Main Business Overview

11.12.5 Cobra Biologics Latest Developments

11.13 REGENXBIO Inc.

11.13.1 REGENXBIO Inc. Company Information

11.13.2 REGENXBIO Inc. Genetic Virus Vector Product Offered

11.13.3 REGENXBIO Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 REGENXBIO Inc. Main Business Overview

11.13.5 REGENXBIO Inc. Latest Developments

11.14 Kaneka Eurogentec S.A.

11.14.1 Kaneka Eurogentec S.A. Company Information

11.14.2 Kaneka Eurogentec S.A. Genetic Virus Vector Product Offered

11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Kaneka Eurogentec S.A. Main Business Overview

11.14.5 Kaneka Eurogentec S.A. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Genetic Virus Vector Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Retroviral Vectors

Table 3. Major Players of Adenoviral Vectors

Table 4. Major Players of Adeno-Associated Viral Vectors

Table 5. Major Players of Other

Table 6. Genetic Virus Vector Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Genetic Virus Vector Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Genetic Virus Vector Market Size Market Share by Type (2017-2022)

Table 9. Genetic Virus Vector Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Genetic Virus Vector Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Genetic Virus Vector Market Size Market Share by Application (2017-2022)

Table 12. Global Genetic Virus Vector Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Genetic Virus Vector Revenue Market Share by Player (2020-2022)

Table 14. Genetic Virus Vector Key Players Head office and Products Offered

Table 15. Genetic Virus Vector Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Genetic Virus Vector Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Genetic Virus Vector Market Size Market Share by Regions (2017-2022)

Table 20. Americas Genetic Virus Vector Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Genetic Virus Vector Market Size Market Share by Country (2017-2022)

Table 22. Americas Genetic Virus Vector Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Genetic Virus Vector Market Size Market Share by Type (2017-2022)

Table 24. Americas Genetic Virus Vector Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Genetic Virus Vector Market Size Market Share by Application (2017-2022)

Table 26. APAC Genetic Virus Vector Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Genetic Virus Vector Market Size Market Share by Region (2017-2022)

Table 28. APAC Genetic Virus Vector Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Genetic Virus Vector Market Size Market Share by Type (2017-2022)

Table 30. APAC Genetic Virus Vector Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Genetic Virus Vector Market Size Market Share by Application (2017-2022)

Table 32. Europe Genetic Virus Vector Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Genetic Virus Vector Market Size Market Share by Country (2017-2022)

Table 34. Europe Genetic Virus Vector Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Genetic Virus Vector Market Size Market Share by Type (2017-2022)

Table 36. Europe Genetic Virus Vector Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Genetic Virus Vector Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Genetic Virus Vector Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Genetic Virus Vector Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Genetic Virus Vector Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Genetic Virus Vector Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Genetic Virus Vector Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Genetic Virus Vector Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Genetic Virus Vector

Table 45. Key Market Challenges & Risks of Genetic Virus Vector

Table 46. Key Industry Trends of Genetic Virus Vector

Table 47. Global Genetic Virus Vector Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Genetic Virus Vector Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Genetic Virus Vector Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Genetic Virus Vector Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Genetic Virus Vector Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Genetic Virus Vector Market Size Market Share Forecast by Application (2023-2028)

Table 53. FUJIFILM Diosynth Biotechnologies U.S.A. Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 54. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product Offered

Table 55. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. FUJIFILM Diosynth Biotechnologies U.S.A. Main Business

Table 57. FUJIFILM Diosynth Biotechnologies U.S.A. Latest Developments

Table 58. Sanofi Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 59. Sanofi Genetic Virus Vector Product Offered

Table 60. Sanofi Main Business

Table 61. Sanofi Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Sanofi Latest Developments

Table 63. Lonza Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 64. Lonza Genetic Virus Vector Product Offered

Table 65. Lonza Main Business

Table 66. Lonza Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Lonza Latest Developments

Table 68. Merck KGaA Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 69. Merck KGaA Genetic Virus Vector Product Offered

Table 70. Merck KGaA Main Business

Table 71. Merck KGaA Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Merck KGaA Latest Developments

Table 73. GENERAL ELECTRIC COMPANY Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 74. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product Offered

Table 75. GENERAL ELECTRIC COMPANY Main Business

Table 76. GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. GENERAL ELECTRIC COMPANY Latest Developments

Table 78. Oxford BioMedica Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 79. Oxford BioMedica Genetic Virus Vector Product Offered

Table 80. Oxford BioMedica Main Business

Table 81. Oxford BioMedica Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Oxford BioMedica Latest Developments

Table 83. Spark Therapeutics, Inc. Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 84. Spark Therapeutics, Inc. Genetic Virus Vector Product Offered

Table 85. Spark Therapeutics, Inc. Main Business

Table 86. Spark Therapeutics, Inc. Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Spark Therapeutics, Inc. Latest Developments

Table 88. uniQure N.V. Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 89. uniQure N.V. Genetic Virus Vector Product Offered

Table 90. uniQure N.V. Main Business

Table 91. uniQure N.V. Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. uniQure N.V. Latest Developments

Table 93. FinVector Vision Therapies Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 94. FinVector Vision Therapies Genetic Virus Vector Product Offered

Table 95. FinVector Vision Therapies Main Business

Table 96. FinVector Vision Therapies Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. FinVector Vision Therapies Latest Developments

Table 98. Brammer Bio Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 99. Brammer Bio Genetic Virus Vector Product Offered

Table 100. Brammer Bio Main Business

Table 101. Brammer Bio Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Brammer Bio Latest Developments

Table 103. Cell and Gene Therapy Catapult Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 104. Cell and Gene Therapy Catapult Genetic Virus Vector Product Offered

Table 105. Cell and Gene Therapy Catapult Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Cell and Gene Therapy Catapult Main Business

Table 107. Cell and Gene Therapy Catapult Latest Developments

Table 108. Cobra Biologics Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 109. Cobra Biologics Genetic Virus Vector Product Offered

Table 110. Cobra Biologics Main Business

Table 111. Cobra Biologics Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Cobra Biologics Latest Developments

Table 113. REGENXBIO Inc. Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 114. REGENXBIO Inc. Genetic Virus Vector Product Offered

Table 115. REGENXBIO Inc. Main Business

Table 116. REGENXBIO Inc. Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. REGENXBIO Inc. Latest Developments

Table 118. Kaneka Eurogentec S.A. Details, Company Type, Genetic Virus Vector Area Served and Its Competitors

Table 119. Kaneka Eurogentec S.A. Genetic Virus Vector Product Offered

Table 120. Kaneka Eurogentec S.A. Main Business

Table 121. Kaneka Eurogentec S.A. Genetic Virus Vector Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Kaneka Eurogentec S.A. Latest Developments

List of Figures

Figure 1. Genetic Virus Vector Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Genetic Virus Vector Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Genetic Virus Vector Market Size Market Share by Type in 2021

Figure 7. Genetic Virus Vector in Gene Therapy

Figure 8. Global Genetic Virus Vector Market: Gene Therapy (2017-2022) & ($ Millions)

Figure 9. Genetic Virus Vector in Vaccinology

Figure 10. Global Genetic Virus Vector Market: Vaccinology (2017-2022) & ($ Millions)

Figure 11. Global Genetic Virus Vector Market Size Market Share by Application in 2021

Figure 12. Global Genetic Virus Vector Revenue Market Share by Player in 2021

Figure 13. Global Genetic Virus Vector Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Genetic Virus Vector Market Size 2017-2022 ($ Millions)

Figure 15. APAC Genetic Virus Vector Market Size 2017-2022 ($ Millions)

Figure 16. Europe Genetic Virus Vector Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Genetic Virus Vector Market Size 2017-2022 ($ Millions)

Figure 18. Americas Genetic Virus Vector Value Market Share by Country in 2021

Figure 19. Americas Genetic Virus Vector Consumption Market Share by Type in 2021

Figure 20. Americas Genetic Virus Vector Market Size Market Share by Application in 2021

Figure 21. United States Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Genetic Virus Vector Market Size Market Share by Region in 2021

Figure 26. APAC Genetic Virus Vector Market Size Market Share by Application in 2021

Figure 27. China Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Genetic Virus Vector Market Size Market Share by Country in 2021

Figure 34. Europe Genetic Virus Vector Market Size Market Share by Type in 2021

Figure 35. Europe Genetic Virus Vector Market Size Market Share by Application in 2021

Figure 36. Germany Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Genetic Virus Vector Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Genetic Virus Vector Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Genetic Virus Vector Market Size Market Share by Application in 2021

Figure 44. Egypt Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Genetic Virus Vector Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 50. APAC Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 51. Europe Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 53. United States Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 54. Canada Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 57. China Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 58. Japan Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 59. Korea Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 61. India Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 62. Australia Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 63. Germany Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 64. France Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 65. UK Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 66. Italy Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 67. Russia Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 68. Spain Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 71. Israel Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Genetic Virus Vector Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Genetic Virus Vector Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450